Global Custom Market Research Reports Provider Company


Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: Sweden

Eurocine Vaccines AB (Eurocine) is a developer of nasal influenza vaccines. The company offers products which include Immunose FLU, a safe and effective influenza vaccine for children. It holds two proprietary adjuvant systems such as Endocine, and a Cationic System, which can be used for nasal vaccination. Eurocine uses clinically validated technology Endocine to develop protected nasal influenza vaccine for needle-free and convenient nasal vaccination in children. The company also develops nasal pneumococcal vaccines that enhance the immune response through stimulation of mucosal immunity. It also out-licenses Immunose FLU for clinical development and commercialization. Eurocine is headquartered in Stockholm, Sweden.

Eurocine Vaccines AB Key Recent Developments

Apr 07,2017: Eurocine Vaccines strengthens organization to develop influenza vaccine

This comprehensive SWOT profile of Eurocine Vaccines AB provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Eurocine Vaccines AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData

Section 1 - About the Company

Eurocine Vaccines AB - Key Information
Eurocine Vaccines AB - Overview
Eurocine Vaccines AB - Key Employees
Eurocine Vaccines AB - Key Employee Biographies
Eurocine Vaccines AB - Key Operational Heads
Eurocine Vaccines AB - Major Products and Services
Eurocine Vaccines AB - History
Eurocine Vaccines AB - Company Statement
Eurocine Vaccines AB - Locations And Subsidiaries
Eurocine Vaccines AB - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Eurocine Vaccines AB - Business Description
Eurocine Vaccines AB - Corporate Strategy
Eurocine Vaccines AB - SWOT Analysis
SWOT Analysis - Overview
Eurocine Vaccines AB - Strengths
Eurocine Vaccines AB - Weaknesses
Eurocine Vaccines AB - Opportunities
Eurocine Vaccines AB - Threats
Eurocine Vaccines AB - Key Competitors

Section 3 - Company Financial Performance Charts

Eurocine Vaccines AB - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Eurocine Vaccines AB, Key Information
Eurocine Vaccines AB, Key Ratios
Eurocine Vaccines AB, Share Data
Eurocine Vaccines AB, Major Products and Services
Eurocine Vaccines AB, History
Eurocine Vaccines AB, Key Employees
Eurocine Vaccines AB, Key Employee Biographies
Eurocine Vaccines AB, Key Operational Heads
Eurocine Vaccines AB, Other Locations
Eurocine Vaccines AB, Subsidiaries
Eurocine Vaccines AB, Key Manufacturing facilities
Eurocine Vaccines AB, Key Competitors
Eurocine Vaccines AB, SWOT Analysis
Eurocine Vaccines AB, Ratios based on current share price
Eurocine Vaccines AB, Annual Ratios
Eurocine Vaccines AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Eurocine Vaccines AB, Performance Chart
Eurocine Vaccines AB, Ratio Charts

Eurocine Vaccines AB (Eurocine) is a developer of nasal influenza vaccines. The company offers products which include Immunose FLU, a safe and effective influenza vaccine for children. It holds two

View Report

Eurocine Vaccines AB (Eurocine) is a developer of nasal influenza vaccines. The company offers products which include Immunose FLU, a safe and effective influenza vaccine for children. It holds two

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports